60.94BMarket Cap14.46P/E (TTM)
157.64High149.33Low9.59KlotVolume155.90Open154.75Pre Close145.37MTurnover1.06%Turnover RatioLossP/E (Static)401.00MShares215.7152wk High12.62P/B13.75BFloat Cap76.3252wk Low185.70Limit Up90.45MShs Float215.71Historical High123.80Limit Down5.37%Amplitude28.75Historical Low--Dividend TTM151.52Avg Price4.54KlotAsk--Div YieldTTM100Lot Size4.62KlotBid
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet